TCG Lifesciences, which runs its informatics business unit under LabVantage Solutions Inc, has acquired the SQL*LIMS business from Applied Biosystems, a part of Life Technologies Corporation, for an undisclosed amount. The acquisition is expected to strengthen TCG Lifesciences’ global presence in the laboratory informatics market.
Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world. TCG Lifesciences Limited, a part of the US-based global investment conglomerate The Chatterjee Group (TCG), has over 200 customers, including 15 of the top 20 global pharmaceutical companies.
“This also facilitates LabVantage’s growth in the forensics and human identification markets and bolsters the strategic expansion plans of TCG Lifesciences,” TCG Lifesciences Chairman Purnendu Chatterjee said in a press release.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
